Crescita Announces Licensing Agreement for Pliaglis; in China
The Pharma Data
NOVEMBER 4, 2020
Juyou will be responsible for the overall clinical development and regulatory filings for Pliaglis with the National Medical Products Administration (the “NMPA”, formerly the China State Food and Drug Administration). . LAVAL, QC, Nov. million and US$1.8 Juyou Bio-Technology Co.,
40 
Let's personalize your content